Veradigm Inc. (NASDAQ:MDRX) Position Cut by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lowered its holdings in shares of Veradigm Inc. (NASDAQ:MDRX) by 26.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,031 shares of the software maker’s stock after selling 3,209 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Veradigm were worth $95,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in MDRX. Pacer Advisors Inc. raised its stake in shares of Veradigm by 108.1% in the 4th quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock worth $26,399,000 after buying an additional 1,307,024 shares in the last quarter. SG Americas Securities LLC purchased a new position in Veradigm during the 4th quarter worth approximately $975,000. Wellington Management Group LLP raised its stake in Veradigm by 92.5% during the 3rd quarter. Wellington Management Group LLP now owns 2,665,814 shares of the software maker’s stock valued at $35,029,000 after purchasing an additional 1,281,319 shares during the period. Creative Planning lifted its holdings in shares of Veradigm by 2,848.4% in the third quarter. Creative Planning now owns 474,376 shares of the software maker’s stock valued at $6,233,000 after purchasing an additional 458,287 shares in the last quarter. Finally, Kent Lake Capital LLC boosted its position in shares of Veradigm by 12.7% in the third quarter. Kent Lake Capital LLC now owns 925,000 shares of the software maker’s stock worth $12,154,000 after buying an additional 104,049 shares during the period.

Veradigm Trading Up 0.3 %

Shares of Veradigm stock opened at $7.98 on Tuesday. The stock has a 50-day simple moving average of $7.74 and a 200-day simple moving average of $9.82. Veradigm Inc. has a 52-week low of $5.01 and a 52-week high of $14.09.

Wall Street Analyst Weigh In

Several research firms recently weighed in on MDRX. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $10.00 price target (down from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. Royal Bank of Canada reduced their price target on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating for the company in a research report on Friday, January 19th. StockNews.com started coverage on shares of Veradigm in a research report on Tuesday, April 23rd. They set a “hold” rating on the stock. Finally, Barclays assumed coverage on shares of Veradigm in a research note on Wednesday, January 3rd. They issued an “equal weight” rating and a $11.00 price objective on the stock. Five equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $11.25.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.